Literature DB >> 28233060

Immunoproteomic Analysis of Antibody Response of Rabbit Host Against Heat-Killed Francisella tularensis Live Vaccine Strain.

Ritu Gaur1, Syed Imteyaz Alam1, Dev Vrat Kamboj2.   

Abstract

Francisella tularensis, the causative agent of tularemia, has attained the status of one of the high priority agents that could be used in the act of bioterrorism. Currently, there is no licensed vaccine for this highly infectious intracellular pathogen. Being a listed 'Category A' agent of the U.S. Center for Disease Control and Prevention (CDC), vaccines and therapeutics are immediately required against this pathogen. In this study, an immunoproteomic approach based on the techniques of 2-dimensional gel electrophoresis (2DE) and immunoblotting combined with mass spectrometry (MS) was used for elucidation of immunogenic components and putative vaccine candidates. Whole-cell soluble protein extract of F. tularensis LVS (Ft LVS) was separated by 2DE, and immunoblots were developed with sera raised in rabbit after immunization with heat-killed Ft LVS. A total of 28 immunoreactive proteins were identified by tandem mass spectrometry. Rabbit immunoproteome of F. tularensis was compared with those previously reported using sera from human patients and in murine model. Out of 28 immunoreactive proteins identified in this study, 12 and 17 overlapping proteins were recognized by human and murine sera, respectively. Nine proteins were found immunogenic in all the three hosts, while eight new immunogenic proteins were found in this study. Identified immunoreactive proteins may find application in design and development of protein subunit vaccine for tularemia.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28233060     DOI: 10.1007/s00284-017-1217-y

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  33 in total

Review 1.  Tularemia as a biological weapon: medical and public health management.

Authors:  D T Dennis; T V Inglesby; D A Henderson; J G Bartlett; M S Ascher; E Eitzen; A D Fine; A M Friedlander; J Hauer; M Layton; S R Lillibridge; J E McDade; M T Osterholm; T O'Toole; G Parker; T M Perl; P K Russell; K Tonat
Journal:  JAMA       Date:  2001-06-06       Impact factor: 56.272

2.  Involvement of Pseudomonas aeruginosa rhodanese in protection from cyanide toxicity.

Authors:  Rita Cipollone; Emanuela Frangipani; Federica Tiburzi; Francesco Imperi; Paolo Ascenzi; Paolo Visca
Journal:  Appl Environ Microbiol       Date:  2006-11-10       Impact factor: 4.792

3.  Mapping of immunoreactive antigens of Francisella tularensis live vaccine strain.

Authors:  Jana Havlasová; Lenka Hernychová; Petr Halada; Vera Pellantová; Jan Krejsek; Jirí Stulík; Ales Macela; Peter R Jungblut; Pär Larsson; Mats Forsman
Journal:  Proteomics       Date:  2002-07       Impact factor: 3.984

4.  Immunoproteomics analysis of the murine antibody response to vaccination with an improved Francisella tularensis live vaccine strain (LVS).

Authors:  Susan M Twine; Mireille D Petit; Kelly M Fulton; Robert V House; J Wayne Conlan
Journal:  PLoS One       Date:  2010-04-02       Impact factor: 3.240

5.  Immunodominant Francisella tularensis antigens identified using proteome microarray.

Authors:  Jim E Eyles; Berkay Unal; Margaret Gill Hartley; Sarah L Newstead; Helen Flick-Smith; Joann L Prior; Petra C F Oyston; Arlo Randall; Yunxiang Mu; Siddiqua Hirst; Douglas M Molina; D Huw Davies; Tim Milne; Kate F Griffin; Pierre Baldi; Rick W Titball; Philip L Felgner
Journal:  Proteomics       Date:  2007-06       Impact factor: 3.984

6.  From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis.

Authors:  Suman Sundaresh; Arlo Randall; Berkay Unal; Jeannine M Petersen; John T Belisle; M Gill Hartley; Melanie Duffield; Richard W Titball; D Huw Davies; Philip L Felgner; Pierre Baldi
Journal:  Bioinformatics       Date:  2007-07-01       Impact factor: 6.937

7.  Immunity to Francisella.

Authors:  Siobhán C Cowley; Karen L Elkins
Journal:  Front Microbiol       Date:  2011-02-16       Impact factor: 5.640

8.  Pneumonic tularemia in rabbits resembles the human disease as illustrated by radiographic and hematological changes after infection.

Authors:  Douglas S Reed; Le'kneitah Smith; Tammy Dunsmore; Anita Trichel; Luis A Ortiz; Kelly Stefano Cole; Eileen Barry
Journal:  PLoS One       Date:  2011-09-13       Impact factor: 3.240

9.  Francisella tularensis LVS surface and membrane proteins as targets of effective post-exposure immunization for tularemia.

Authors:  Jeffrey C Chandler; Marjorie D Sutherland; Marisa R Harton; Claudia R Molins; Rebecca V Anderson; Darragh G Heaslip; Catharine M Bosio; John T Belisle
Journal:  J Proteome Res       Date:  2014-12-29       Impact factor: 4.466

10.  Immunoproteomic analysis of proteins expressed by two related pathogens, Burkholderia multivorans and Burkholderia cenocepacia, during human infection.

Authors:  Minu Shinoy; Ruth Dennehy; Lorraine Coleman; Stephen Carberry; Kirsten Schaffer; Máire Callaghan; Sean Doyle; Siobhán McClean
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

View more
  4 in total

1.  Simultaneous Immunodetection of Anthrax, Plague, and Tularemia from Blood Cultures by Use of Multiplexed Suspension Arrays.

Authors:  Adva Mechaly; Einat Vitner; Haim Levy; Shay Weiss; Elad Bar-David; David Gur; Michal Koren; Hila Cohen; Ofer Cohen; Emanuelle Mamroud; Morly Fisher
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

2.  Identification of Cross Reactive Antigens of C. botulinum Types A, B, E & F by Immunoproteomic Approach.

Authors:  Arti Sharma; Sarkaraisamy Ponmariappan; Rani Sarita; Syed Imtiaz Alam; Dev Vrat Kamboj; Sangeeta Shukla
Journal:  Curr Microbiol       Date:  2018-01-13       Impact factor: 2.188

Review 3.  What Room for Two-Dimensional Gel-Based Proteomics in a Shotgun Proteomics World?

Authors:  Katrin Marcus; Cécile Lelong; Thierry Rabilloud
Journal:  Proteomes       Date:  2020-08-06

4.  Inhibition of Francisella tularensis phagocytosis using a novel anti-LPS scFv antibody fragment.

Authors:  Adva Mechaly; Uri Elia; Ron Alcalay; Hila Cohen; Eyal Epstein; Ofer Cohen; Ohad Mazor
Journal:  Sci Rep       Date:  2019-08-06       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.